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HCV Behavioral Health Preparation of the Racial/Ethnic Minority: Measurement Development of a HCV
Treatment Readiness Tool in Spanish and English
Michele M. Vella, Joseph Yozviak, D.O., Judith Lash, R.N.
Lehigh Valley Hospital Hepatitis Care Center
Hepatitis C: A Background of Disparities

The Intersection of HCV, Health Disparities & Psychology

Overview
• Approximately 3.2 million persons are affected with Hepatitis C
(HCV) in the United States (CDC, 2011)
• It is estimated that there are 17,000 new cases of HCV every year
though fewer than 1,000 are reported (Daniels et al., 2009)
• HCV can persist for decades without symptoms (CDC, 2011)
• 65%-75% of infected Americans are unaware of their infection
(CDC, 2011)

The Color of Disparity
• African Americans (A.A.) are twice as likely to be infected with
HCV compared to the general U.S. population (El-Seraq et al., 2010)
• Though A.A. make up 12% of the U.S. population, they account for
22% of HCV cases (El-Seraq et al., 2010)
• Persons residing in the Commonwealth of Puerto Rico have more
than 2 times the rate of HCV antibodies (6-10%) compared to
persons residing in Mainland U.S. (0.9-4.3%) (Perez et al., 2007)
• American Indians and Alaskan Natives are 2.8 times as likely to
develop HCV than Whites (CDC, 2011)

HIV + HCV + Racial/Ethnic Minority = Triple Jeopardy

Participants
• It is estimated that 30%-40% of persons infected with HIV are coinfected with HCV (CDC, 2011)
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• Average age of 27 years (SD = 4.59)

The Neuropsychiatric Burden of HCV
• Like HIV, HCV is a neurotrophic virus that causes alterations of
sub-cortical brain structures (Hafliger, 2008)
• HIV & HCV co-infected individuals may suffer viral alterations on
the sub-cortical brain areas, damage caused by hyperammonemia,
and basilar manganese deposition due to persistent hepatic
encephalopathy
Behavioral Health Considerations for HCV Treatment
• Chemotherapy agents are used to treat HCV. Persons electing
treatment may or may not be cured of the virus. These medication
therapies may cure up to 80% of HCV (Porter & Franciscus, 2009)
• These medications, however, carry considerable physical and
psychological effects including: depression, anxiety, irritability,
tearfulness, rage, decreased frustration tolerance,
were
mania/hypomania, suicidal ideation, psychosis in the absence of
delirium (co-infected patients), cognitive dysfunction, generalized
slowing, decreased attention span, reduced executive skills, and
fatigue (Hafliger, 2008; Hoffman et al., 2003; Onyike et al., 2004).
• Psychological distress may lead to discontinuation of treatment.
Hence, pre-existing negative behavioral health symptoms (i.e.,
mental health and substance use) must be minimized before
starting treatment.
• Racial/ethnic minorities infected with HCV and/or HIV are likely
to have compounded barriers to quality infectious disease and
behavioral healthcare that could impact treatment completion
(OMH, 2012; SAMHSA, 2011)
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Hypothesized dimensions were based on a literature review of
multicultural, behavioral health, and clinical variables of
HCV populations, qualitative and quantitative HCV
treatment experience, and data on treatment outcomes
A pool of 46 items were drafted were based on studies related
to the 4 domains including:
a.)Coping : items generated from the intersection of health
disparities with psychosocial coping styles with
consideration to multicultural competency and HCV
population characteristics
b.)Trauma: items generated from Adverse Childhood
Experience Study to determine trauma history and trauma’s
relationship with coping, behavioral health, and HCV
treatment motivation (CDC, 2012; Felitti et al., 1998)
c.)Behavioral health: items generated from SAMHSA
considerations of behavioral health of minority communities
and mental health and substance use/abuse impact on HCV
(Fireman et al., 2005; SAMHSA, 2011)
d.)Motivation: items generated from stages of change and
treatment adherence n chronic disease populations (Wiley et
al., 2000)

Survey Participants, Survey Measures & Future
Directions
•Convenience sample of HCV positive adults being
treated at LVHN HCC, over 18 years of age, and being
evaluated for HCV treatment from January 2012 until
January 2013
•Participants are clinically interviewed to record sociodemographic characteristics including gender, age,
race/ethnicity, employment status, education,
knowledge of HCV, and self-report route of infection
•After socio-demographic data are gathered the 46 item
assessment is administered by the LVHN HCC
behavioral health specialist in compliance with chronic
HCV standard of care
•Scores are assigned to each subscale domain (0=No,
1=Sometimes, 2=Yes) with a higher sum total equaling
the need for increased LVHN HCC team support
•From January 2012 until July 2012, a total of (x) HCC
assessments have completed the assessment.
(women/men) with a mean age of “x” (range x-x years)
with the following racial/ethnic groups represented:
African American (n=2), Latino (n=), Native American
(n=1) , Asian American (n=), and White (n=)
•Assessments will be administered until January 2013
whereby data analysis, construct validity and construct
validity will be analyzed retrospectively to determine

